QTracer expands to Brazil
QTracer expands to Brazil. Brazil is one of the largest and fast growing emerging healthcare markets in the world and a commercially attractive region to invest.
QTracer has entered into a long-term distribution agreement with mServices who has acquired exclusive rights on the sale of the software solution. According the agreement, mServices assumes full responsibility for the marketing, sales and services in Brazil. We are proud to introduce it to Brazil and delighted to have mServices as a partner.
The move to Brazil fits into QTracer’s ambitions to help healthcare organizations in the continuous improvement of patient safety and quality of care globally by providing software to support accreditation processes. Brazil is an exciting market with excellent growth potential, and many hospitals will benefit from the improved patient safety and care that our software solution makes possible.
Accreditation in Brazil
In Brazil, there is no law, nor encouragement by governments or health care providers requiring health institutions to seek accreditation. Many Brazilian hospital organizations believe that application of accreditation standards may contribute to the improvement of Patient safety and reduction of medical errors by raising the standard of quality.
Brazil leads Latin America in the development of accreditation systems. The main accrediting organizations are the National Accreditation Organization (ONA) and the Joint Commission International (JCI). About 8% of Brazil’s more than 6,000 hospitals are accredited. This contrasts with over 90% accreditation rates in US and over 80% in Canada. ONA accredited 487 Brazilian hospitals and JCI accredited 53 institutions (2016 data from the Ministry of Health).
The overwhelming majority of accredited hospitals are concentrated on the Southeast Region (SER), the most economically developed region of the country. The location of mServices, Rio de Janeiro, with dedicated sales in São Paulo, is therefore an ideal base to serve the Brazilian hospital market.
mServices is locally owned and operated by Danilo Meth. The company already successfully provides medication adherence customized solutions for healthcare organizations in order to address the wide spread phenomena of medication non-compliance. At the core of the solution is a cloud-based software, enabling the remote deployment, management and monitoring of smart medication dispensers and vital sign monitors. With their solid healthcare and technology expertise mServices can provide added value services to QTracer customers. The company has already started QTracer proof-of-concept implementations in several Brazilian hospital organizations.
In the fulfillment of its tasks mServices works in close relationship with the Consortium for Brazilian Accreditation (CBA). CBA is recognized as a reference in the provision of accreditation services and international certification systems and health education in Brazil. JCI and CBA since 2000 assesses jointly the compliance of healthcare organizations in Brazil with universal standards to improve the safety and quality of care provided to patients. QTracer will be introduced at the upcoming international CBA congress that is taking place in Rio de Janeiro, 17th – 19th September 2017. Some of the speakers; David Bates (professor of medicine at the Harvard Medical School), Paula Wilson (CEO at Joint Commission International). Attendees will then have the opportunity to get more familiar with the new QTracer software of mServices.